These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 26703278

  • 1. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S, Ram J, Bansal R, Pandav SS, Gupta A.
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K, Ota I, Miyake G, Numaga J.
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS, Kennard MG, Boghossian AJ.
    Adv Ther; 2007 May; 24(6):1278-85. PubMed ID: 18165210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
    Heier JS, Awh CC, Busbee BG, Waterbury LD, Daniel P, Stoller GL, Cleary TS.
    Retina; 2009 Oct; 29(9):1310-3. PubMed ID: 19934822
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP, De Castro LE, Vroman DT, Solomon KD.
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
    Cagini C, Pellegrino A, Cerquaglia A, Iaccheri B, Lupidi M, Fiore T.
    Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437
    [Abstract] [Full Text] [Related]

  • 14. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
    Lane SS, Modi SS, Lehmann RP, Holland EJ.
    J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C, Salsini G, Perri P.
    Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
    [Abstract] [Full Text] [Related]

  • 16. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW, Chung BH, Kim EK, Seo KY, Kim TI.
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
    Brookshire HL, English RV, Nadelstein B, Weigt AK, Gift BW, Gilger BC.
    Vet Ophthalmol; 2015 May; 18(3):175-85. PubMed ID: 24636042
    [Abstract] [Full Text] [Related]

  • 19. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
    Warren KA, Bahrani H, Fox JE.
    Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
    [Abstract] [Full Text] [Related]

  • 20. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, Formisano D, Fontana L.
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.